Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-C Report: Assessment of Patient Scenarios (Derivation Cohort) and Refinement of Definitions

Autoimmune Disease

Assessment of triple antiphospholipid antibody-positive patients based on clinical and laboratory domains of 2023 ACR/EULAR antiphospholipid syndrome classification criteria

Semin Arthritis Rheum

Cobanoglu RK, Vega J, Burgos C, Erkan D

doi: 10.1016/j.semarthrit.2025.152768

Rheumatoid Arthritis

EULAR/ACR risk stratification criteria for development of rheumatoid arthritis in the risk stage of arthralgia

Ann Rheum Dis

van Steenbergen HW, Doornkamp F, Alivernini S, Backlund J, Codreanu C, Cohen SB, Combe B, Cope AP, Deane KD, England BR, Falahee M, de Jong PHP, Kleyer A, Lacaille D, Maat B, Mankia K, van Mulligen E, Nagy G, O'Neil LJ, Rodamaker L, Sahbudin I, van Schaardenburg D, Sepriano A, da Silva JAP, De Smet L, Sparks JA, Steyerberg EW, Studenic P, Wethington E, Landewé RL, Raza K, van der Helm-van Mil AHM

doi: 10.1016/j.ard.2025.01.021

Autoimmune Disease

Recurrent thrombosis and hemorrhagic events in a large single-center primary antiphospholipid syndrome cohort: Results from APS-Rio cohort after nearly 1,000 patient-years of follow-up

Semin Arthritis Rheum

Signorelli F, Balbi GGM, Bastos VP, Reis-Carvalho T, Klumb EM, Levy RA

doi: 10.1016/j.semarthrit.2025.152873

Rheumatoid Arthritis

Towards the development of a definition of independence for individuals diagnosed with rheumatoid arthritis in remission: an 'OMERACT remission in rheumatoid arthritis patient perspective' special interest group report

Semin Arthritis Rheum

Gazel U, Barnes E, Jones B, Terrett A, Voshaar M, Hoogland W, March L, Beaton D, Khoo T, Chin A, Shea B, Tugwell P, Proudman S, Flurey CA

doi: 10.1016/j.semarthrit.2026.152948

Systemic Lupus Erythematosus

Certolizumab pegol to prevent adverse pregnancy outcomes in patients with antiphospholipid syndrome and lupus anticoagulant (IMPACT): results of a prospective, single-arm, open-label, phase 2 trial

Ann Rheum Dis

Branch DW, Kim MY, Guerra MM, Worden J, Laskin CA, DeSancho MT, Landres IV, Knight JS, Slosberg HS, Minett M, Salmon JE

doi: 10.1016/j.ard.2025.02.012

Osteoarthritis

Magnetic Resonance Imaging Derived Cartilage Morphological Changes and their Correlation with Patient-Reported Outcome Measures Following Knee Joint Distraction for Osteoarthritis: A 12-Month Cohort Study

Cartilage

Lineham B, Joumah A, Hamilton T, Wijayathunga N, Pandit H

doi: 10.1177/19476035251357836

Autoimmune Disease

Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome

Ann Rheum Dis

David C, Nathan N, Al-Abadi E, Arkwright PD, Bader-Meunier B, Becker S, Belot A, Brennan M, Breton S, Bondet V, Cadranel J, Coulomb l'Hermine A, De Almeida S, Duffy D, Poch TC, de Becdelièvre A, El Khalifi-Boulisfane S, Gattorno M, Gispert-Saüch M, Gothe F, Hatchuel Y, Herdliczko D, Kilinc AA, Koucky V, Labouret G, Manna R, Maillard H, Matoses Ruipérez ML, Matucci-Cerinic C, Mensa-Vilaro A, Michel K, Molina TJ, Lopez Montesinos B, Newman WG, Papenkort J, Rapp C, Rames C, Rice GI, Rose MA, Reumaux H, Sailler L, Schwerk N, Seabra L, Sellam J, Taddio A, Thumerelle C, Tommasini A, Tusseau M, Volpi S, Wetzke M, Weiss L, Welfringer-Morin A, Wislez M, Griese M, Crow YJ, Frémond ML

doi: 10.1016/j.ard.2025.09.013

Rheumatoid Arthritis

Disease activity predicts the development of cardiovascular events in patients with rheumatoid arthritis from the CARMA cohort

Semin Arthritis Rheum

Llorca J, Ferraz-Amaro I, Castañeda S, Plaza Z, Sánchez-Alonso F, García-Gómez C, González-Juanatey C, González-Gay MÁ, CARMA Project Collaborative Group

doi: 10.1016/j.semarthrit.2025.152833

Further Publications Rheumatology

Almost half of the patients with axial spondyloarthritis reporting an acceptable symptom state have high disease activity; data from two standard-of-care cohorts

Semin Arthritis Rheum

Carbo M, Kampman A, Paap D, Wink F, Webers C, Vonkeman H, van Tubergen A, Arends S, Spoorenberg A

doi: 10.1016/j.semarthrit.2025.152903

Related content

Assessment of triple antiphospholipid antibody-positive patients based on clinical and laboratory domains of 2023 ACR/EULAR antiphospholipid syndrome classification criteria

EULAR/ACR risk stratification criteria for development of rheumatoid arthritis in the risk stage of arthralgia

Recurrent thrombosis and hemorrhagic events in a large single-center primary antiphospholipid syndrome cohort: Results from APS-Rio cohort after nearly 1,000 patient-years of follow-up

Towards the development of a definition of independence for individuals diagnosed with rheumatoid arthritis in remission: an 'OMERACT remission in rheumatoid arthritis patient perspective' special interest group report

Certolizumab pegol to prevent adverse pregnancy outcomes in patients with antiphospholipid syndrome and lupus anticoagulant (IMPACT): results of a prospective, single-arm, open-label, phase 2 trial

Magnetic Resonance Imaging Derived Cartilage Morphological Changes and their Correlation with Patient-Reported Outcome Measures Following Knee Joint Distraction for Osteoarthritis: A 12-Month Cohort Study

Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome

Disease activity predicts the development of cardiovascular events in patients with rheumatoid arthritis from the CARMA cohort

Almost half of the patients with axial spondyloarthritis reporting an acceptable symptom state have high disease activity; data from two standard-of-care cohorts